Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Vr Adviser, Llc > Profile

Instuitional Investor - Vr Adviser, Llc

Fund Profile
Filing Period:
Fund Name: Vr Adviser, Llc
Portfolio Value $3,298,051,614
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Apogee Therapeutics Inc.
 APGE 8,493,321 $1,127,318,496 34.18%
2.
Oruka Therapeutics Inc.
 ORKA 4,148,428 $394,805,893 11.97%
3.
Erasca Inc.
 ERAS 17,891,812 $327,777,996 9.94%
4.
Spyre Therapeutics Inc.
 SYRE 2,985,448 $265,048,073 8.04%
5.
Dianthus Therapeutics Inc.
 DNTH 1,180,000 $115,026,400 3.49%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.